[Evercord-KY] Announcement of Board Resolution to Lift Non-Compete Restrictions for Managers
Evercord-KY announced that its board of directors has resolved to lift the non-compete restrictions for Co-CEO Lu Kong-Ming, permitting him to hold concurrent positions in several investment and biotech companies.
📋 Article Processing Timeline
- 📰 Published: May 29, 2026 at 09:00
- 🔍 Collected: May 30, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:12 (34h 12m after Collected)
1. Board resolution date: 115/05/29. 2. Name and title of manager permitted to engage in competitive behavior: Lu Kong-Ming, Co-CEO. 3. Items of permitted competitive behavior: Chairman of Diamond High-Tech Investment, Diamond No. 1 Investment, Elite Investment, New Horizon Biotech Investment; Director of Oneness (Shanghai) Biotech, Oneness (HK) Biotech, Megabio Inc. (HK), Microbio Pharmaceutical; Chairman of Oneness (USA) Biotech. 4. Period: During his tenure as manager of the company. 5. Resolution status: Approved unanimously by all attending directors. 6. Engagement in Mainland China business: Lu Kong-Ming, Co-CEO. 7. Company name and title in Mainland China: Director of Oneness (Shanghai) Biotech. 8. Address: No. 1188, Guangxing Rd, Songjiang District, Shanghai. 9. Business scope: Pharmaceutical production, technology development, consulting, etc. 10. Impact on company: None. 11. Investment amount and shareholding ratio: US$5.705 million, 10.88%. 12. Other matters: None.
FAQ
Why was the non-compete clause for Lu Kong-Ming lifted?
To allow him to hold concurrent positions in group-related companies.